MTSRMID

Metsera, Inc.

HealthcareBiotechnology
$70.50
$0.00(+0.00%)
52W$26.25
$83.86
Updated Jun 30, 02:00 AM
RSI62
RS Rating92/99
Beta-1.04
Volatility125%
F-Score3/9
Mkt Cap$7.4B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Metsera, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is leading (RS Rating: 92), indicating clear outperformance against the broad market. Earnings growth of 50% provides fundamental context to the price action. However, price is extended 32% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
92
out of 99
Market Leader
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
-1.04
vs S&P 500
LOW VOL
52W Position
77%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$53.47
50 SMA > 100 SMA$
100 SMA > 150 SMA$
150 SMA > 200 SMA$35.09

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$63.54+10.95%ABOVE
50 SMA$53.47+31.85%ABOVE
100 SMA$
150 SMA$
200 SMA$35.09+100.91%ABOVE

Price Performance

1D+0.0%
1W
1M
3M
6M
YTD
1Y+147.8%
3Y+38.6%
52-Week Trading Range77% from low
$70.50
52W Low$26.25
52W High$83.86

Technical Indicators

RSI (14)BULLISH
62.1
305070
Setup ScoreCOOL
1/10
Base depth: 73.9%

Risk Profile

Beta
-1.04
52W Vol
125%
ATR
$
Max DD (1Y)
-32%

Volume Analysis

Today
50D Avg
Vol Ratio
x
Liquidity
MODERATE

Earnings Momentum

Q4'24
$-0.51
Q1'25
$-0.74
Q2'25
$-0.66
Q3'25+50%
$-1.11
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR

10 Years:+10.28%
5 Years:+21.62%
3 Years:+38.56%
1 Year:+147.80%

Return on Equity

10Y Avg:-78.2%
5Y Avg:-78.2%
3Y Avg:-78.2%
Last Year:-93.2%

Key Metrics

Market Cap$7.4B
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is MTSR in an uptrend right now?

MTSR has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is MTSR overbought or oversold?

MTSR's RSI (14) is 62. The stock is in neutral territory, neither overbought nor oversold.

Is MTSR outperforming the market?

MTSR has a Relative Strength (RS) Rating of 92 out of 99. Yes, MTSR is a market leader, outperforming 92% of all stocks over the past 12 months.

Where is MTSR in its 52-week range?

MTSR is trading at $70.50, which is 84% of its 52-week high ($83.86) and 77% above its 52-week low ($26.25).

How volatile is MTSR?

MTSR has a Beta of -1.04 and 52-week volatility of 125%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.